![](/img/cover-not-exists.png)
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group
M.S Aapro, F.H van Wijk, M.E.L van der Burg, W ten Bokkel Huinink, I Vergote, J.P Guastalla, R Rosso, A Kobierska, L.V.A Beex, M Namer, T.E.W Splinter, J.B VermorkenVolume:
39
Year:
2003
Language:
english
DOI:
10.1016/s0959-8049(03)00198-9
File:
PDF, 91 KB
english, 2003